Rachel Friedman, MD
Gynecology · New York, NYNPI 1811988264
Payments from drug & device makers
Across 43 payments — averaging $22.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$225
- Astellas Pharma US Inc$199
- Organon$117
- Sanofi Pasteur Inc.$79
- Coopersurgical, Inc.$69
- Amarin Pharma, Inc.$46
- plus $212 from 10 others
What the payments were for
- Food & beverage$92998%
- Education$182%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 10 | $225 |
| Astellas Pharma US Inc | 9 | $199 |
| Organon | 2 | $117 |
| Sanofi Pasteur Inc. | 4 | $79 |
| Coopersurgical, Inc. | 3 | $69 |
| Amarin Pharma, Inc. | 2 | $46 |
| Bayer | 2 | $44 |
| Millicent US Inc | 2 | $31 |
| Merck | 2 | $24 |
| Mylan Pharmaceuticals Inc. | 1 | $19 |
| Hologic Sales And Service, LLC | 1 | $19 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Renovia Inc | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Avion Pharmaceuticals | 1 | $11 |
How this compares
$948 in reported general payments places this provider in the 55th percentile of 240 gynecology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 149 | $14,468 |
| EstringEstradiol | 20 | $10,366 |
| PremarinEstrogens, Conjugated | 17 | $9,427 |
| YuvafemEstradiol | 25 | $3,790 |
| ValacyclovirValacyclovir Hcl | 31 | $1,869 |
| Clobetasol Propionate | 34 | $756 |
| ProgesteroneProgesterone, Micronized | 21 | $635 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 18 | $324 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 22 | $283 |
| Acyclovir | 13 | $139 |
| Fluconazole | 17 | $63 |
Paid to pharmacies, not to this prescriber.
Other gynecology in New York
- Arnold AdvinculaNew York$2.2M
- Paula CastanoNew York$784K
- Rhoda SperlingNew York$266K
- Tamara KolevNew York$91K
- Charles Ascher-WalshNew York$43K
- Christopher EswarNew York$25K
- Neena AgarwalaNew York$17K
- Anne DavisNew York$17K
- Tara AllmenNew York$8K
- Jorge VenegasNew York$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.